Advertisement

Topics

Pharmaceutica Limited Company Profile

14:25 EST 14th November 2018 | BioPortfolio

Pharmaceutica Limited is a privately owned pharmaceutical company founded in March 2003, to discover and develop a new generation of anti-infective drug technologies that combat the increasing problem caused by the rapid evolution of resistance by pathogenic organisms. The company is targeting both human and veterinary applications for its technologies.
The initial focus is to find a solution to the growing problem of antibiotic resistance in bacteria. For more than twenty years, the founders of Pharmaceutica have been searching for a solution to this problem and have discovered certain molecules that are capable of transforming antibiotic resistant bacteria into antibiotic-susceptible bacteria. These molecules, known as Bacterial Transforming Agents, may be combined with existing antibiotics to produce new drugs which are active against antibiotic-resistant bacteria, including methicillin resistant Staphylococcus aureus (‘MRSA’). Such drugs could also be used in first-line treatment of bacterial infections to prevent the emergence of new antibiotic resistance.

Location

Unit 58G Arthur Street Lakeside
Redditch
Worcestershire
B98 8JY
United Kingdom

Contact

Phone: 44 (0) 1527 524050
Fax: 44 (0) 1527 524740
Email: mel@pharma-bta.com


News Articles [64 Associated News Articles listed on BioPortfolio]

Basilea Pharmaceutica: Gesamtumsatz um 30% gesteigert - Ausblick für Gesamtumsatz 2018 erhöht

Bad Marienberg (www.anleihencheck.de) - Basilea Pharmaceutica AG (ISIN CH0011432447WKN: A0B9GA) (SIX: BSLN) gab heute die Finanzergebnisse für das erste Halbjahr bis 30. Juni 2018 bekannt, so das U.....

Janssen Pharmaceutica grants Saladax exclusive rights to diagnostics-related patents

Janssen Pharmaceutica NV licensed Saladax Biomedical Inc. exclusive worldwide rights to patents related to diagnostics for determining antipsychotic drug levels.

Janssen Pharmaceutica NV Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Report Updated: 30032018] Prices from USD $350

Janssen Pharmaceutica NV Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's Janssen Pharmaceutica NV Mergers Acquisitions MA, Partnerships Alliances and Inve...

Janssen Pharmaceutica NV Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Report Updated: 28072018] Prices from USD $350

Janssen Pharmaceutica NV Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's Janssen Pharmaceutica NV Mergers Acquisitions MA, Partnerships Alliances and Inve...

Janssen Pharmaceutica NV Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Report Updated: 23042018] Prices from USD $350

Janssen Pharmaceutica NV Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's Janssen Pharmaceutica NV Mergers Acquisitions MA, Partnerships Alliances and Inve...

Edison Investment Research Limited: Edison issues outlook on Basilea Pharmaceutica (BSLN)

Dow Jones received a payment from EQS/DGAP to publish this press release. Edison Investment Research Limited Edison Investment Research Limited: Edison issues outlook on Basilea Pharmaceutica (BSL...

Basilea Pharmaceutica (BSLN) - Cresemba growth, pipeline expansion

Edison Investment Research - Pharmaceutical & healthcare - Basilea Pharmaceutica: Basilea reported a strong set of interim 2018 results; H118 total revenues grew to CHF59.9m (+30%, H117 CHF46.2m). Not...

Basilea Pharmaceutica AG 2018 Q2 - Results - Earnings Call Slides

PubMed Articles [29 Associated PubMed Articles listed on BioPortfolio]

The Structure and Activity of Double-Nitroimidazoles. A Mini-Review.

Many interesting applications have been found for nitroimidazoles as therapeutic agents. Among others, some of these compounds can radiosensitize hypoxic tumor cells. The introduction of a second nitr...

Anti-retroviral drugs: current state and development in the next decade.

The pace of discovery of new antiretroviral (ARV) drugs has slowed, although the efficacy and safety of once-daily fixed dose combinations have been extensively investigated. Several traditional ARV d...

Separation and simultaneous quantitation of PGF2 and its epimer 8--PGF2 using modifier-assisted differential mobility spectrometry tandem mass spectrometry.

Because many therapeutic agents are contaminated by epimeric impurities or form epimers as a result of metabolism, analytical tools capable of determining epimers are increasingly in demand. This arti...

Spectrofluorimetric method for atenolol determination based on gold nanoparticles.

A simple and sensitive spectrofluorimetric method for determination of atenolol (ATE) using gold nanoparticles (AuNPs) was developed. The method is based on the quenching effect of atenolol on photolu...

An updated overview on the development of new photosensitizers for anticancer photodynamic therapy.

Photodynamic therapy (PDT), based on the photoactivation of photosensitizers (PSs), has become a well-studied therapy for cancer. Photofrin, belonging to the first generation of PS, is still widely us...

Clinical Trials [3 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence and Wear Study of Mylan Fentanyl Transdermal System 25 µg/h and Mylan Fentanyl Transdermal System

The objective of this study was to investigate the effect of three different types of occlusive overlays on the drug delivery of Fentanyl Transdermal Systems, 25 mcg/h manufactured for Myl...

Study of the Effect of Clinical Procedures on Drug Delivery of Mylan Fentanyl Transdermal System 25 µg/hr and Duragesic® 25 µg/hr

The objective of this study was to investigate the effect of clinical procedures on the drug delivery of Fentanyl Transdermal Systems, 25 mcg/h manufactured for Mylan Pharmaceuticals Inc. ...

Vaginal Misoprostol Before IUD Insertion in Women With Cesarean Scar

Groups of study: 120 candidates for Cu T 380A IUD insertion were enrolled in the study. They were divided into two groups: Group 1: Sixty women received 600 micrograms of misoprostol vagi...

Companies [92 Associated Companies listed on BioPortfolio]

Basilea Pharmaceutica AG

Basilea Pharmaceutica AG is an independent biopharmaceutical company actively engaged in the discovery and development of innovative drugs for the treatment of bacterial infections, fungal infections ...

Pharmaceutica Limited

Pharmaceutica Limited is a privately owned pharmaceutical company founded in March 2003, to discover and develop a new generation of anti-infective drug technologies that combat the increasing problem...

Janssen Pharmaceutica N.V.

Microsulis Medical Limited

Founded in 1997, Microsulis Medical Limited is a UK-based medical device company that exploits specialist intellectual property in medical microwave design to create therapeutic d...

Aurora Biomolecules

Aurora Biomolecules is situated in the heart of Cambridge & specialises in polyclonal antibody production and peptide synthesis for academia, pharmaceutica and industry.anti-GFP antibodiesContract man...

More Information about "Pharmaceutica Limited" on BioPortfolio

We have published hundreds of Pharmaceutica Limited news stories on BioPortfolio along with dozens of Pharmaceutica Limited Clinical Trials and PubMed Articles about Pharmaceutica Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Pharmaceutica Limited Companies in our database. You can also find out about relevant Pharmaceutica Limited Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

MRSA (methicillin-resistant Staphylococcus aureus)
MRSA (methicillin-resistant Staphylococcus aureus) is a family of bacteria with resistance to one or more major antibiotics. There are currently 17 different strains of MRSA. Two particular strains, EMRSA15 and EMRSA16  account for 96% of MRSA blood...


Corporate Database Quicklinks



Searches Linking to this Company Record